Tag Archives: Risperdal

Reduced Use of Antipsychotics for Dementia Does Not Improve Outcomes for Nursing Home Residents

January 15, 2025 By: Martha Garcia

Residents taken off antipsychotics were given more antidepressant, anxiety, sedative, anticonvulsant, mood stabilizer and anti-dementia medications.
Antipsychotics Linked to Heart Failure, Stroke, Other Health Risks in Dementia Patients: Study

May 03, 2024 By: Martha Garcia

Findings come amid continuing concerns about the overuse of antipsychotics for dementia patients in long-term care facilities, which is considered a form of "chemical restraint" or nursing home abuse.
Case Study Suggests Even Low-Dose Risperdal Side Effects May Cause Tardive Dyskinesia Movement Disorders

December 14, 2022 By: Irvin Jackson

Reports of Riperdal causing tardive dyskinesia have been outlined in medical literature, raising concerns that side effects of the antipsychotic medication may cause the involuntary movement problems
$70 Million Verdict in Risperdal Lawsuit Upheld After U.S. Supreme Court Declines To Review

May 18, 2021 By: Irvin Jackson
Antipsychotics Boxed Warning Curbed Use As “Chemical Restraint” In Nursing Homes: Study

April 30, 2020 By: Russell Maas
Judge Determines Johnson & Johnson Should Be Required to Pay $6.8M in Punitive Damage For Failing to Warn About Risperdal Risks

January 20, 2020 By: Irvin Jackson
Psychotropic Drugs May Cause Weight Gain By Altering Your Genes: Study

January 17, 2020 By: Martha Garcia
Only 1% of Serious Adverse Drug Events Reported To FDA: Report

December 19, 2019 By: Irvin Jackson
Johnson & Johnson Lawsuits Over Talcum Powder, Opioids and Other Products May Cost Over $20B to Settle: Report: WSJ

October 15, 2019 By: Irvin Jackson
Risperdal Lawsuit Results in $8B Verdict Against Johnson & Johnson Over Breast Growth Side Effects for Males

October 09, 2019 By: Irvin Jackson

Lawsuit Claims Ultra-Processed Foods Caused Childhood Diabetes and Fatty Liver Disease (Posted 5 days ago)

One of the first ultra-processed foods lawsuits has been filed by a Pennsylvania man, indicating several major food and beverage companies deliberately engineered their products to be addictive and harmful.

Judge Clears BioZorb Breast Marker Lawsuit To Move Forward, Rejecting Motion for Summary Judgment (Posted 6 days ago)

In a ruling likely to apply broadly across the litigation, a federal judge is refusing to dismiss a BioZorb marker lawsuit, clearing the way for other claims to move forward.

Bard PowerPort MDL Judge Allows More Time To Select Next Round of Bellwether Cases (Posted 7 days ago)

Lawyers are currently completing discovery in a group of 15 Bard PowerPort lawsuits, which will then be narrowed down to six potential trial claims by mid-April 2025.

Tag Archives: Risperdal

Reduced Use of Antipsychotics for Dementia Does Not Improve Outcomes for Nursing Home Residents

Antipsychotics Linked to Heart Failure, Stroke, Other Health Risks in Dementia Patients: Study

Case Study Suggests Even Low-Dose Risperdal Side Effects May Cause Tardive Dyskinesia Movement Disorders

$70 Million Verdict in Risperdal Lawsuit Upheld After U.S. Supreme Court Declines To Review

Antipsychotics Boxed Warning Curbed Use As “Chemical Restraint” In Nursing Homes: Study

Judge Determines Johnson & Johnson Should Be Required to Pay $6.8M in Punitive Damage For Failing to Warn About Risperdal Risks

Psychotropic Drugs May Cause Weight Gain By Altering Your Genes: Study

Only 1% of Serious Adverse Drug Events Reported To FDA: Report

Johnson & Johnson Lawsuits Over Talcum Powder, Opioids and Other Products May Cost Over $20B to Settle: Report: WSJ

Risperdal Lawsuit Results in $8B Verdict Against Johnson & Johnson Over Breast Growth Side Effects for Males

More Top Stories

Review A Case